Thursday, January 10, 2008

Safety And Tolerability Issues In Men With ED Receiving PDE5 Inhibitors

Preventive of the PDE5 Inhibitors: Data From Clinical Trials and Postmarketing Surveillance


Which AEs Occur Most Frequently with PDE5 Inhibitors?

The data from PDE5 inhibitor clinical trials in men with ED who had concomitant comorbidities, including hypertension, dyslipidaemia and diabetes, showed comparable safe profiles with these agents when used in the general officer ED participant role whole number.
This is a part of article Safety And Tolerability Issues In Men With ED Receiving PDE5 Inhibitors Taken from "Buy Levitra Viagra Online" Information Blog

No comments: